东方证券股份有限公司 关于 上海晶华胶粘新材料股份有限公司 2024年度以简易程序向特定对象发行股票 之 上市保荐书 保荐机构（主承销商） （上海市黄浦区中山南路119号东方证券大厦） 二〇二五年四月 上海晶华胶粘新材料股份有限公司 上市保荐书（注册稿） 3-2-1 | 目 录 2 | | | --- | --- | | 一、保荐机构名称 3 | | | 二、保荐机构指定保荐代表人 3 | | | 三、本次保荐的发行人名称 3 | | | 四、本次保荐的发行人基本情况 3 | | | 五、发行人主要风险提示 7 | | | 六、申请上市的股票发行情况 11 | | | 七、保荐机构是否存在可能影响其公正履行保荐职责情形的说明 14 | | | 八、保荐机构承诺事项 14 | | | 九、本次证券发行上市履行的决策程序 15 | | | 十、保荐人对发行人符合以简易程序向特定对象发行股票并上市条件的说明 16 | | | 十一、对发行人持续督导期间的工作安排 32 | | | 十二、保荐机构工作人员及其保荐业务执业情况 33 | | | 十三、保荐机构认为应当说明的其他事项 34 | | | 十四、保荐机构对本 ...

东方证券股份有限公司 关于 上海晶华胶粘新材料股份有限公司 2024年度以简易程序向特定对象发行股票 之 发行保荐书 保荐机构（主承销商） （上海市黄浦区中山南路119号东方证券大厦） 二〇二五年四月 上海晶华胶粘新材料股份有限公司 发行保荐书（注册稿） 声 明 上海晶华胶粘新材料股份有限公司（以下简称"晶华新材""发行人"或 "公司"）拟申请以简易程序向特定对象发行普通股股票（以下简称"本次证 券发行""本次发行"或"向特定对象发行股票"），并已聘请东方证券股份 有限公司（以下简称"东方证券"）作为本次证券发行的保荐机构（以下简称 "保荐机构"或"本机构"）。 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《证券发行上市保荐业务管 理办法》（以下简称"《保荐管理办法》"）、《上市公司证券发行注册管理 办法》（以下简称"《注册管理办法》"）、《发行证券的公司信息披露内容 与格式准则第 27 号——发行保荐书和发行保荐工作报告》（以下简称"《准则 第 27 号》"）、《保荐人尽职调查工作准则》等法律法规和中国证券监督管理 委员会（以下简称"中国证监 ...

Revenue and Profit - In Q1 2025, the company achieved a total revenue of 438 million yuan, representing a year-on-year growth of 12.67% [1] - However, the net profit attributable to shareholders declined from 21.58 million yuan in the same period of 2024 to 18.79 million yuan, a decrease of 12.92% [1] - The non-recurring net profit also fell from 21.05 million yuan to 18.58 million yuan, a year-on-year reduction of 11.73% [1] Key Financial Indicators - The gross margin for Q1 2025 was 16.84%, down by 1.79 percentage points compared to the previous year [2] - The net profit margin was 4.43%, reflecting a year-on-year decrease of 21.73% [2] - Total selling, administrative, and financial expenses amounted to 37.21 million yuan, accounting for 8.5% of revenue, an increase of 6.47% year-on-year [2] - Earnings per share (EPS) was 0.07 yuan, a decrease of 23.4% year-on-year [2] - The net asset per share was 5.16 yuan, showing a year-on-year growth of 3.3% [2] - Operating cash flow per share was 0.08 yuan, significantly increasing by 746.56% year-on-year [2] Accounts Receivable and Cash Flow - As of the end of Q1 2025, accounts receivable stood at 328 million yuan, a year-on-year increase of 21.13% [3] - Accounts receivable accounted for 490.04% of the latest annual net profit, indicating a significant risk in receivables collection [3] - Cash and cash equivalents were 137 million yuan, a substantial decrease of 57.04% from 319 million yuan in the same period last year [3] - The ratio of cash to current liabilities was only 21.61%, raising concerns about the company's cash flow situation [3] Debt Situation - Interest-bearing liabilities increased from 596 million yuan in Q1 2024 to 757 million yuan in Q1 2025, a year-on-year growth of 26.92% [4] - The interest-bearing asset-liability ratio reached 26.78%, necessitating attention to the company's debt repayment capacity [4] Business Model and Capital Operations - The company's performance is primarily driven by R&D, equity financing, and capital expenditures [5] - Since its listing, the total financing amount has reached 732 million yuan, with total dividends amounting to 70.94 million yuan, resulting in a dividend financing ratio of 0.1 [5] - Investors should focus on the rationality of capital expenditure projects and potential funding pressures [5] Summary - Overall, while the company experienced revenue growth in Q1 2025, profit declined, and there are notable risks associated with accounts receivable, cash flow, and debt situation that require ongoing monitoring [6]

证券代码：603683 证券简称：晶华新材 公告编号：2025-029 上海晶华胶粘新材料股份有限公司 2025年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第 3 号行业信 息披露：第十三号——化工》的要求，现将上海晶华胶粘新材料股份有限公司（以 下简称"公司"）2025 年第一季度主要经营数据披露如下（均不含税）： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 年 2025 | 1-3 | 月产 | 年 2025 1-3 | 月销量 | 年 2025 | 月销售金 1-3 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 量（万平方米） | | | （万平方米） | | | 额（万元） | | 电子胶粘材料 | | | 1,080.35 | | 1,713.71 | | 12,766.89 | | 工业胶粘材料 | | 12,807.84 | | | 11,158.3 ...

1 2024 年环境、社会及管治报告 | 关于本报告 | | --- | | 董事长致辞 | | 集团组织架构 | | --- | | 发展历程 | | 2024 年度大事记 | | 对联合国可持续发展目标的贡献 | | Z对气候变化 | 23 | | --- | --- | | 下境应急合规管理 | 25 | | 染物排放 | 29 | | 弃物处理 | 35 | | :源利用 | 38 | | 〈资源利用 | 41 | | 酥经济 | 43 | | -态系统和生物多样性保护 | 44 | | 企业管治 | | --- | | 可持续发展管理 | | 风险管理 | | 重要性议题评估 | | 创新驱动 | 47 | | --- | --- | | 产品和服务安全与质量 | 51 | | 数据安全与客户隐私保护 | 55 | | 供应链安全 | 57 | | 员工责任 | 59 | | 乡村振兴 | 71 | | 社会贡献 | 72 | | pray 슬理 | | | --- | --- | | 职调查 | 77 | | 益相关方沟通 | 77 | | 商业贿赂及反贪污 | 79 | | 不正当竞争 | 83 ...

第四届董事会第十九次会议决议公告 证券代码：603683 证券简称：晶华新材 公告编号：2025-028 上海晶华胶粘新材料股份有限公司 （一）审议通过《公司 2025 年第一季度报告》 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况： （一）本次会议的召集、召开符合《公司法》等有关法律、法规、规章和《公司章 程》的规定，会议决议合法有效。 （二）上海晶华胶粘新材料股份有限公司(以下简称"公司")第四届董事会第十九 次会议通知及会议材料于 2025 年 4 月 24 日以电话、传真、电子邮件或专人送达的方式 分送全体参会人员。 （三）本次会议于 2025 年 4 月 28 日 13:30 在公司会议室以现场和通讯相结合的方 式召开。 （四）本次会议应到董事 7 名，实到董事 7 名。 （五）会议由董事长周晓南先生召集并主持。公司监事及高级管理人员列席了本次 会议。 二、董事会会议审议情况： 经出席会议的董事审议并以记名方式投票表决通过了如下议案： 表决结果：7 票同意，0 票反对，0 票弃权。 该事项已 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 438,015,694.57, representing a 12.67% increase compared to CNY 388,751,633.43 in the same period last year[4]. - Net profit attributable to shareholders decreased by 12.92% to CNY 18,790,723.23 from CNY 21,579,719.61 year-on-year[4]. - Basic and diluted earnings per share decreased by 23.40% to CNY 0.072 from CNY 0.094 in the same period last year[4]. - Total operating revenue for Q1 2025 reached ¥438,015,694.57, an increase of 12.7% compared to ¥388,751,633.43 in Q1 2024[21]. - Net profit for Q1 2025 was ¥19,413,508.69, a decrease of 11.1% from ¥22,013,707.99 in Q1 2024[22]. - Operating profit for Q1 2025 was ¥19,375,508.57, down 14.3% from ¥22,732,837.87 in Q1 2024[22]. - Basic earnings per share for Q1 2025 were ¥0.072, down from ¥0.094 in Q1 2024[22]. - The company's revenue for Q1 2025 was ¥28,292,851.06, a decrease of 52.8% compared to ¥60,013,524.82 in Q1 2024[31]. - Operating profit for Q1 2025 was -¥3,731,528.00, compared to an operating profit of ¥5,729,304.56 in Q1 2024[31]. - Net profit for Q1 2025 was -¥2,597,363.77, a significant decline from a net profit of ¥6,792,148.85 in Q1 2024[32]. Cash Flow and Assets - The net cash flow from operating activities improved significantly to CNY 22,176,935.89, compared to a negative cash flow of CNY -3,381,523.59 in the previous year[4]. - In Q1 2025, the company generated operating cash inflow of ¥384,344,155.83, an increase of 7.5% compared to ¥357,444,998.47 in Q1 2024[24]. - The net cash flow from operating activities was ¥22,176,935.89, recovering from a negative cash flow of ¥3,381,523.59 in the same period last year[24]. - Cash and cash equivalents at the end of Q1 2025 totaled ¥131,349,001.08, down from ¥313,607,830.63 at the end of Q1 2024[25]. - Cash flow from operating activities in Q1 2025 was -¥9,120,225.70, compared to -¥43,538,628.77 in Q1 2024, indicating an improvement[35]. - Cash and cash equivalents at the end of Q1 2025 were ¥8,509,063.65, down from ¥150,193,884.70 at the end of Q1 2024[35]. - The company reported investment cash inflows of ¥32,768,409.28 in Q1 2025, down from ¥105,337,360.00 in Q1 2024[35]. - The net cash flow from investing activities for Q1 2025 was -¥2,157,590.72, compared to a positive net cash flow of ¥94,397,680.44 in Q1 2024[35]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,670,733,370.84, an increase of 4.36% from CNY 2,559,168,579.63 at the end of the previous year[5]. - Total assets as of the reporting date were ¥2,670,733,370.84, an increase from ¥2,559,168,579.63 in the previous period[18]. - Total liabilities amounted to ¥1,307,352,099.95, up from ¥1,219,896,854.99 in the previous period[18]. - The company's total liabilities were ¥218,535,981.65, compared to ¥217,705,375.11 at the end of 2024, indicating a slight increase[29]. - The total equity of the company reached ¥1,393,495,524.10, up from ¥1,391,236,810.55 at the end of 2024[29]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 24,248[8]. - Major shareholders include Zhou Xiaonan with 17.62% and Zhou Xiaodong with 16.32% of shares, with Zhou Xiaodong's shares being pledged[9]. - Shareholders' equity attributable to shareholders increased by 1.75% to CNY 1,353,741,806.87 from CNY 1,330,490,295.89[5]. - Shareholders' equity reached ¥1,363,381,270.89, compared to ¥1,339,271,724.64 in the previous period, indicating a growth of 1.8%[18]. Investment and Development - The company plans to invest ¥300 million in the construction of a high-end electronic adhesive materials production and R&D center to enhance its core competitiveness in the consumer electronics and new energy sectors[12]. - The company has submitted a registration application for a simplified procedure to issue A-shares, which has been approved by the Shanghai Stock Exchange and is currently in the registration phase with the China Securities Regulatory Commission[13]. Expenses - Total operating costs for Q1 2025 were ¥419,571,604.45, up 14.1% from ¥367,832,542.37 in Q1 2024[21]. - Research and development expenses increased to ¥16,066,151.43 in Q1 2025, compared to ¥13,078,404.34 in Q1 2024, reflecting a growth of 22.7%[21]. - The company incurred financial expenses of ¥535,683.30 in Q1 2025, compared to ¥478,710.82 in Q1 2024[31]. - The company’s sales expenses increased to ¥1,236,139.24 in Q1 2025 from ¥990,938.80 in Q1 2024[31].

东方证券股份有限公司 关于上海晶华胶粘新材料股份有限公司 向特定对象发行股票之保荐总结报告书 根据中国证券监督管理委员会《关于核准上海晶华胶粘新材料股份有限公 司非公开发行股票的批复》（证监许可[2023]247 号），并经上海证券交易所同 意，公司 2022 年度向特定对象发行股票数量为 44,062,929 股，每股面值为人民 1.00 元，发行价格为人民币 9.90 元/股，此次发行募集资金总额为人民币 436,222,997.10 元，扣除本次发行费用 12,264,335.45 元（不含增值税）后募集资 金净额为 423,958,661.65 元。本次发行股票于 2023 年 7 月在上海证券交易所主 板上市，光大证券股份有限公司为晶华新材 2022 年度向特定对象发行股票的保 荐机构。 公司于 2024 年 12 月 23 日与东方证券股份有限公司（以下简称"东方证 券"）签订了《上海晶华胶粘新材料股份有限公司与东方证券股份有限公司关 于向特定 对象发行人民币普通股之保荐协议》（以下简称"《保荐协议》"）， 聘请东方证券担任公司 2024 年度以简易程序向特定对象发行股票的保荐机构， 并负责公司 ...

| 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制 | 保荐机构已制定持续督导计划，并依据 | | | 度，并针对具体的持续督导工作制定相 | | | | 应的工作计划 | 工作计划开展持续督导工作 | | | 根据中国证监会相关规定，在持续督导 | | | | 工作开始前，与上市公司或相关当事人 | 保荐机构已与晶华新材签订《保荐协 | | | | 议》，该协议明确了双方在持续督导期 | | 2 | 签署持续督导协议，明确双方在持续督 | 间的权利和义务，并报上海证券交易所 | | | 导期间的权利义务，并报上海证券交易 | 备案 | | | 所备案 | | | | 通过日常沟通、定期回访、现场检查、 | 保荐机构通过日常沟通、定期或不定期 | | 3 | 尽职调查等方式开展持续督导工作 | 回访、现场检查等方式，了解业务情 | | | | 况，对公司开展持续督导工作 | | | 持续督导期间，按照有关规定对上市公 司违法违规事项公开发表声明的，应于 | 晶华新材在持续督导期间未发生按有关 | | 4 | | 规定须保荐机构公开 ...

东方证券股份有限公司 关于上海晶华胶粘新材料股份有限公司 2024 年度持续督导现场检查报告 根据《证券发行上市保荐业务管理办法》《上海证券交易所上市公司自律 监管指引第 11 号——持续督导》等有关法律法规的规定，东方证券股份有限 公司（以下简称"东方证券"）作为履行上海晶华胶粘新材料股份有限公 司（以下简称"晶华新材"或"公司"）2022 年度向特定对象发行股票持续督 导工作的保荐机构，对公司 2024 年度的规范运作情况进行了现场检查，现就 现场检查的有关情况及公司首次公开发行股票募集资金的使用情况报告如下： 一、本次现场检查的基本情况 （一）保荐机构 东方证券股份有限公司 （二）保荐代表人 张桐、许恒栋 （三）现场检查时间 2025 年 4 月 16 日-2025 年 4 月 18 日 （四）现场检查人员 张桐 （五）现场检查内容 公司治理和内部控制情况、信息披露情况、公司的独立性以及与控股股东、 实际控制人及其他关联方资金往来情况、募集资金使用情况、关联交易、对外 担保、重大对外投资情况、公司经营情况和承诺履行情况等。 （六）现场检查手段 1、查看上市公司主要生产经营场所； 2、访谈上市公司高级管理 ...